
doi: 10.1007/bf00265935
pmid: 1623911
The pharmacokinetics of nifurtimox, a drug used in the treatment of Trypanosoma cruzi infections, has been studied in seven patients with chronic renal failure undergoing haemodialysis, and in seven healthy subjects. Each subject took nifurtimox 15 mg.kg-1 orally and blood samples were obtained for 10 h after administration. Nifurtimox in serum was analyzed by HPLC. The patients with chronic renal failure had a higher Cmax than the control subjects due to a change in systemic availability. An alternative explanation would be that both the distribution volume and the clearance had changed. The mean half-life in the patients with chronic renal failure was similar to that in the healthy subjects.
Insuficiencia Renal Crónica - Metabolismo, Adult, Male, renal failure, Metabolic Clearance Rate, 610, Changas' disease, Middle Aged, Renal Dialysis, 03 Salud y bienestar, Humans, Kidney Failure, Chronic, 03 Good Health and Well-being, Female, Nifurtimox, Medicina y salud, pharmacokinetics, Diálisis renal
Insuficiencia Renal Crónica - Metabolismo, Adult, Male, renal failure, Metabolic Clearance Rate, 610, Changas' disease, Middle Aged, Renal Dialysis, 03 Salud y bienestar, Humans, Kidney Failure, Chronic, 03 Good Health and Well-being, Female, Nifurtimox, Medicina y salud, pharmacokinetics, Diálisis renal
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 28 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
